Case number 1:20-cv-00093
Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 12, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Magistrate Judge Burke for the purpose of exploring ADR. Please see the Court's Standing Order No. 2022-2 dated March 14, 2022. (dlb) |
| May 5, 2020 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-00651-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO 18-651-CFC ONLY. (nmf) |
| May 5, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:19-cv-00926-CFC, 19 in 1:19-cv-00560-CFC, 20 in 1:19-cv-00685-CFC) Joint STIPULATION & Proposed Order for Consolidation by Vanda Pharmaceuticals Inc., (20 in 1:20-cv-00235-CFC, 129 in 1:18-cv-00651-CFC, 25 in 1:19-cv-02202-CFC, 133 in 1:18-cv-00690-CFC, 21 in 1:20-cv-00093-CFC, 132 in 1:18-cv-00689-CFC, 20 in 1:20-cv-00083-CFC, 23 in 1:19-cv-02375-CFC, 18 in 1:20-cv-00318-CFC) Stipulation filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 5/5/2020. Associated Cases: 1:18-cv-00651-CFC et al.(nmf) |
| Apr 21, 2020 | 21 | Stipulation (4) Docket Text: Joint STIPULATION & Proposed Order for Consolidation by Vanda Pharmaceuticals Inc.. (Jacobs, Karen) |
| Apr 17, 2020 | 20 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Apr 17, 2020 | 19 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Disclosure of Accused Products and the Asserted Patents filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Apr 13, 2020 | 18 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of (1) Plaintiff Vanda Pharmaceuticals Inc.s Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1); and (2) Vanda Pharmaceuticals Inc.s Supplemental Disclosures Pursuant to Delaware Default Standard for Discovery Including Discovery of Electronically Stored Information filed by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| Apr 10, 2020 | 17 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's Rule 26 Initial Disclosures filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Apr 2, 2020 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 4/2/2020. (Court Reporter V. Gunning.) Associated Cases: 1:19-cv-02202-CFC et al.(nmf) |
| Apr 2, 2020 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf Associated Cases: 1:19-cv-02202-CFC et al.(cak) |
| Apr 2, 2020 | 16 | Scheduling Order (26) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 8/14/2020. Amended Pleadings due by 8/14/2020. Fact Discovery completed by 11/20/2020. Expert Discovery due by 4/30/2021. Dispositive Motions due by 5/21/2021. Joint Claim Construction Brief due by 8/7/2020. A Markman Hearing is set for 8/19/2020 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 6/9/2021. A Final Pretrial Conference is set for 6/30/2021 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 7/19/2021 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 4/2/2020. Associated Cases: 1:19-cv-02202-CFC et al.(nmf) |
| Mar 31, 2020 | 15 | Main Document (26) Docket Text: PROPOSED ORDER Joint Proposed Scheduling Order by Vanda Pharmaceuticals Inc.. (Attachments: # (1) K. Jacobs cover letter to Judge Connolly)(Jacobs, Karen) |
| Mar 31, 2020 | 15 | K. Jacobs cover letter to Judge Connolly (2) |
| Mar 12, 2020 | 14 | Order Setting Scheduling Conference (3) Docket Text: Order Setting Scheduling Conference: A Scheduling Conference is set for 4/2/2020 at 03:30 PM in Courtroom 4B before Judge Colm F. Connolly. If the parties have no disputes about scheduling, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 3/12/2020. Associated Cases: 1:19-cv-02202-CFC et al.(nmf) |
| Mar 2, 2020 | 13 | Answer to Counterclaim (4) Docket Text: ANSWER to [9] Answer to Complaint, Counterclaim by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| Feb 26, 2020 | 12 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Karen Jacobs regarding Status Report. (Jacobs, Karen) |
| Feb 18, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (14 in 1:19-cv-02375-CFC, 11 in 1:20-cv-00093-CFC, 12 in 1:20-cv-00083-CFC, 15 in 1:19-cv-02202-CFC) STIPULATION TO EXTEND TIME to file a joint submission regarding the parties' proposal for coordination/consolidation to February 26, 2020 filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 2/18/2020. Associated Cases: 1:19-cv-02202-CFC, 1:19-cv-02375-CFC, 1:20-cv-00083-CFC, 1:20-cv-00093-CFC(fms) |
| Feb 14, 2020 | 11 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME to file a joint submission regarding the parties' proposal for coordination/consolidation to February 26, 2020 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Feb 13, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Nicholas Groombridge, Daniel J. Klein, Jennifer Rea Deneault for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-00083-CFC, 1:20-cv-00093-CFC(kmd) |
| Feb 12, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Josephine Young and Kira A. Davis for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-00083-CFC, 1:20-cv-00093-CFC(mal) |
| Feb 12, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney John C. Rozendaal, and William H. Milliken for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d), Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-02202-CFC, 1:20-cv-00093-CFC(sam) |
| Feb 12, 2020 | 9 | Answer to Complaint (11) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Vanda Pharmaceuticals Inc. by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Feb 12, 2020 | 10 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Feb 11, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [8] MOTION for Pro Hac Vice Appearance of Attorney J.C. Rozendaal and William H. Milliken filed by Teva Pharmaceuticals USA, Inc. Signed by Judge Colm F. Connolly on 2/11/2020. (fms) |
| Feb 11, 2020 | 8 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney J.C. Rozendaal and William H. Milliken - filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Feb 7, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Eric Alan Stone for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Jan 30, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (8 in 1:20-cv-00083-CFC, 7 in 1:20-cv-00093-CFC) MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Kira A. Davis, Josephine Young, Daniel J. Klein and Jennifer Rea Deneault filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 1/30/2020. Associated Cases: 1:20-cv-00083-CFC, 1:20-cv-00093-CFC(nmf) |
| Jan 30, 2020 | 7 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Kira A. Davis, Josephine Young, Daniel J. Klein and Jennifer Rea Deneault - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jan 29, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:20-cv-00083-CFC, 1:20-cv-00093-CFC (rjb) |
| Jan 24, 2020 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Vanda Pharmaceuticals Inc.. Teva Pharmaceuticals USA, Inc. served on 1/23/2020, answer due 2/13/2020. (Jacobs, Karen) |
| Jan 22, 2020 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceuticals USA, Inc. on 1/22/2020. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (myr) |
| Jan 22, 2020 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate BlackRock, Inc. for Vanda Pharmaceuticals Inc. filed by Vanda Pharmaceuticals Inc. (myr) |
| Jan 22, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,449,176. (myr) |
| Jan 22, 2020 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: December 20, 2019. Date of Expiration of Patent: January 25, 2033.Thirty Month Stay Deadline: 7/31/2021. (myr) |
| Jan 22, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Jan 22, 2020 | 1 | Civil Cover Sheet (1) |
| Jan 22, 2020 | 1 | Exhibit A (37) |
| Jan 22, 2020 | 1 | Main Document (10) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-2831704.) - filed by Vanda Pharmaceuticals Inc.. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(myr) |
| Jan 22, 2020 | 1 | Complaint* (1) |
